UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
______________________________
FORM 6-K
______________________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
______________________________
For the month of August 2026
Commission File Number: 001-43304
OPTIMI HEALTH CORP.
______________________________
269 David Brown Way
Princeton, B.C. V0X 1W0
Canada
(Address of principal executive office)
______________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
|
Exhibit |
Description of Exhibit | |
| 99.1 | Management's Discussion and Analysis for the period ended June 30, 2026 | |
| 99.2 | Condensed interim consolidated financial statements for the period ended June 30, 2026 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| OPTIMI HEALTH CORP. | |||
| Date: August 14, 2026 | By: | /s/ Dane Stevens | |
| Name: | Dane Stevens | ||
| Title: | Chief Executive Officer, Chief Marketing Officer and Director | ||